Related Experiment Video
Updated: Jul 9, 2026
05:34
Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Clinical implications of airway hyperresponsiveness in COPD
Nicola Scichilone1, Salvatore Battaglia, Alba La Sala
1Istituto di Medicina Generale e Pneumologia, Cattedra di Malattie dell'Apparato Respiratorio, Università di Palermo, Palermo, Italy. n.scichilone@libero.it
International Journal of Chronic Obstructive Pulmonary Disease
|December 1, 2007
Summary
Airway hyperresponsiveness (AHR) is common in COPD, affecting at least half of patients. AHR is linked to reduced lung function, smoking, and predicts mortality, but may help differentiate COPD from asthma.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Medicine
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a major global cause of death.
- Airway hyperresponsiveness (AHR) is a common finding in COPD patients.
- Understanding AHR in COPD is crucial for clinical practice and patient outcomes.
Purpose of the Study:
- To evaluate the relationship between AHR and COPD.
- To assess the clinical relevance of AHR in COPD management.
- To explore the role of AHR in differentiating COPD from asthma.
Main Methods:
- A comprehensive MEDLINE search was conducted, identifying 1919 articles.
- Eligible studies focused on AHR prevalence, pathogenesis, and prognosis in COPD.
- Data synthesis focused on determinants and clinical implications of AHR.
Main Results:
- AHR is present in over 50% of individuals with COPD.
- Key determinants of AHR include reduced lung function and smoking status.
- AHR is an independent predictor of mortality in COPD patients.
Conclusions:
- AHR plays a dual role in COPD: aiding differential diagnosis and predicting prognosis.
- Physicians can use AHR characteristics to distinguish COPD from asthma.
- Smoking cessation may reduce AHR, warranting further investigation into its impact on lung function and symptoms.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...